Skip to main content
Clinical Trials/ACTRN12620000493943
ACTRN12620000493943Withdrawn未知

Prospective study evaluating the proportion of SARS-CoV-2 (COVID-19) antibody seroconversion in frontline health care workers on serial evaluation in comparison to symptom presentation.

Albury Wodonga Health0 sites50 target enrollmentStarted: April 20, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Withdrawn
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • •Participants aged 18 years or over
  • •Participants who are front-line health care workers that may have cared for SARS-CoV-2 positive patients and/or been involved in testing suspected SARS-CoV-2 patients and/or work in a high-risk setting. High-risk setting is defined as the Emergency Department, Intensive Care, Medical wards caring for patients with COVID-19 or dialysis unit
  • •Participants must be accessible for follow up testing
  • •Able to read, write and understand English Participant Information and Consent Form
  • •Signed Participant Information and Consent Form

Exclusion Criteria

  • •Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the protocol
  • •Research study personnel as identified in this Protocol

Investigators

Similar Trials